Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Virology. 2021 Jan 28;556:39–61. doi: 10.1016/j.virol.2021.01.012

Figure 6:

Figure 6:

Non-invasive near-infrared fluorescence (NIRF) bioimaging using Cy5.5-GdPhMV particles decorated with DGEA peptide (or with PEG, control group) for targeting prostate tumors in athymic nude mice following I.V. injection of 200 μg. (A) Longitudinal visualization of PhMV particles using NIRF imaging. (B) In vivo localization of PhMV particles in the RES organs. (C) Long-term quantitation of fluorescence signals in prostate tumors. (D) Ex vivo NIRF imaging of major organs 240 hours post-injection. (E) Organs distribution/biodistribution profiles of Cy5.5-Gd-PhMV-DGEA particles using ex vivo NIRF imaging data – control group being untreated animals. Reprinted from [90], Copyright 2019, with permission from American Chemical Society.